False negative NIPT results: Risk figures for chromosomes 13,18 and 21 based on chorionic villi results in 5967 cases and literature review

PLoS ONE

Volumn 11, Issue 1, 2016, Pages

  Van Opstal, Diane ^a   Srebniak, Malgorzata I ^a   Polak, Joke ^a   De Vries, Femke ^a   Govaerts, Lutgarde C P ^a   Joosten, Marieke ^a   Go, Attie T J I ^a   Knapen, Maarten F C M ^a,b   Van Den Berg, Cardi ^a   Diderich, Karin E M ^a   Galjaard, Robert Jan H ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Stichting Prenatale Screening Zuidwest Nederland   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANEUPLOIDY; ARTICLE; CHORION VILLUS; CONTROLLED STUDY; CYTOGENETICS; CYTOTROPHOBLAST; FALSE NEGATIVE RESULT; FEMALE; GENETIC RISK; HUMAN; HUMAN TISSUE; KARYOTYPE; MOSAICISM; NON INVASIVE PRENATAL TESTING; NON INVASIVE PROCEDURE; PRENATAL DIAGNOSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; TRISOMY 13; TRISOMY 18; TRISOMY 21; CHROMOSOME 13; CHROMOSOME 18; GENETICS; HUMAN CHROMOSOME; METABOLISM; PREGNANCY;

CHORIONIC VILLI; CHROMOSOMES, HUMAN, 21-22 AND Y; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 18; FEMALE; HUMANS; PREGNANCY;

EID: 84955318079     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0146794     Document Type: Article

References (33)

1. Bianchi DW, Wilkins-Haug L. Integration of noninvasive DNA testing for aneuploidy into prenatal care: what has happened since the rubber met the road? Clin Chem. 2014;60(1):78-87. Epub 2013/11/21. doi: clinchem.2013.202663 [pii]
2. Flori E, Doray B, Gautier E, Kohler M, Ernault P, Flori J, et al. Circulating cell-free fetal DNA in maternal serum appears to originate from cyto- and syncytio-trophoblastic cells. Case report. Hum Reprod. 2004;19(3):723-4. Epub 2004/03/05.
3. Srebniak MI, Diderich KE, Noomen P, Dijkman A, deVries FA, van Opstal D. Abnormal non-invasive prenatal test results concordant with karyotype of cytotrophoblast but not reflecting abnormal fetal karyotype. Ultrasound Obstet Gynecol. 2014;44(1):109-11. Epub 2014/03/04.
4. Faas BH, de Ligt J, Janssen I, Eggink AJ, Wijnberger LD, van Vugt JM, et al. Non-invasive prenatal diagnosis of fetal aneuploidies using massively parallel sequencing-by-ligation and evidence that cellfree fetal DNA in the maternal plasma originates from cytotrophoblastic cells. Expert Opin Biol Ther. 2012;12 Suppl 1:S19-26. Epub 2012/04/17.
5. Simoni G, Brambati B, DanesinoC, Rossella F, Terzoli GL, Ferrari M, et al. Efficient direct chromosome analyses and enzyme determinations from chorionic villi samples in the first trimester of pregnancy. Hum Genet. 1983;63(4):349-57. Epub 1983/01/01. PMID: 6862440.
6. Gibas LM, Grujic S, Barr MA, Jackson LG. A simple technique for obtaining high quality chromosome preparations from chorionic villus samples using FdU synchronization. Prenat Diagn. 1987;7(5):323-7. Epub 1987/06/01. PMID: 2956585.
7. Smidt-Jensen S, Christensen B, Lind AM. Chorionic villus culture for prenatal diagnosis of chromosome defects: reduction of the long-term cultivation time. Prenat Diagn. 1989;9(5):309-19. Epub 1989/05/01. PMID: 2657708.
8. van den Berg C, Van Opstal D, Brandenburg H, Wildschut HI, den Hollander NS, Pijpers L, et al.. Accuracy of abnormal karyotypes after the analysis of both short- and long-term culture of chorionic villi. Prenat Diagn. 2000;20(12):956-69. Epub 2000/12/13.
9. Sachs ES, JahodaMG, Los FJ, Pijpers L, ReussA, Wladimiroff JW. Interpretation of chromosome mosaicism and discrepancies in chorionic villi studies. Am J Med Genet. 1990;37(2):268-71. Epub 1990/10/01.
10. Crane JP, Cheung SW. An embryogenic model to explain cytogenetic inconsistencies observed in chorionic villus versus fetal tissue. Prenat Diagn. 1988;8(2):119-29. Epub 1988/02/01. PMID: 3362778.
11. Bianchi DW, Wilkins-Haug LE, EndersAC, Hay ED. Origin of extraembryonic mesoderm in experimental animals: relevance to chorionic mosaicism in humans. Am J Med Genet. 1993;46(5):542-50. Epub 1993/06/15.
12. Pittalis MC, Dalpra L, Torricelli F, Rizzo N, Nocera G, Cariati E, et al. The predictive value of cytogenetic diagnosis after CVS based on 4860 cases with both direct and culture methods. Prenat Diagn. 1994;14(4):267-78. Epub 1994/04/01. PMID: 8066036.
13. Wolstenholme J. Confined placental mosaicism for trisomies 2, 3, 7, 8, 9, 16, and 22: their incidence, likely origins, and mechanisms for cell lineage compartmentalization. Prenat Diagn. 1996;16(6):511-24. Epub 1996/06/01. PMID: 8809892.
14. KalousekDK, Barrett I. Confined placental mosaicism and stillbirth. Pediatr Pathol. 1994;14(1):151-9. Epub 1994/01/01. PMID: 8159612.
15. Battaglia P, Baroncini A, Mattarozzi A, Baccolini I, Capucci A, Spada F, et al. Cytogenetic follow-up of chromosomal mosaicism detected in first-trimester prenatal diagnosis. Prenat Diagn. 2014;34(8):739-47. Epub 2014/03/19.
16. Gao Y, Stejskal D, Jiang F, Wang W. False-negative trisomy 18 non-invasive prenatal test result due to 48, XXX, +18 placental mosaicism. Ultrasound Obstet Gynecol. 2014;43(4):477-8. Epub 2013/11/05.
17. Wolstenholme J, Evans J, English C. A45, X fetus with false-negative 46, XX findings in CVS. Prenat Diagn. 2008;28(3):266-7. Epub 2008/02/28.
18. Canick JA, Palomaki GE, Kloza EM, Lambert-Messerlian GM, Haddow JE. The impact of maternal plasma DNA fetal fraction on next generation sequencing tests for common fetal aneuploidies. Prenat Diagn. 2013;33(7):667-74. Epub 2013/04/18.
19. Benn P, Cuckle H, Pergament E. Non-invasive prenatal testing for aneuploidy: current status and future prospects. Ultrasound Obstet Gynecol. 2013;42(1):15-33. Epub 2013/06/15.
20. Gregg AR, Gross SJ, Best RG, Monaghan KG, Bajaj K, Skotko BG, et al. ACMG statement on noninvasive prenatal screening for fetal aneuploidy. Genet Med. 2013;15(5):395-8. Epub 2013/04/06. doi: gim201329 [pii]
21. Benn P, Borell A, Chiu R, Cuckle H, Dugoff L, Faas B, et al. Position statement from the Aneuploidy Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis. Prenat Diagn. 2013;33(7):622-9. Epub 2013/04/26.
22. Bianchi DW, Platt LD, Goldberg JD, Abuhamad AZ, Sehnert AJ, Rava RP, et al. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet Gynecol. 2012;119(5):890-901. Epub 2012/03/01.
23. van den Berg C, Van Opstal D, Polak-Knook J, Galjaard RJ. (Potential) false-negative diagnoses in chorionic villi and a review of the literature. Prenat Diagn. 2006;26(5):401-8. Epub 2006/03/16.
24. KalousekDK, Dill FJ, Pantzar T, McGillivray BC, Yong SL, Wilson RD. Confined chorionic mosaicism in prenatal diagnosis. Hum Genet. 1987;77(2):163-7. Epub 1987/10/01. PMID: 3653890.
25. Grati FR, Malvestiti F, Ferreira JC, Bajaj K, Gaetani E, Agrati C, et al. Fetoplacental mosaicism: potential implications for false-positive and false-negative noninvasive prenatal screening results. Genet Med. 2014;16(8):620-4. Epub 2014/02/15. doi: gim20143 [pii]
26. Toutain J, Van-Gils J, Horovitz J, Saura R. Comment on "QF-PCR as a substitute for karyotyping of cytotrophoblastforthe analysis of chorionic villi: advantages and limitations from a cytogenetic retrospective audit of 44 727 first-trimester prenatal diagnoses". Prenat Diagn. 2013;33(11):1115-6. Epub 2013/07/23.
27. Toutain J, Epiney M, Begorre M, Dessuant H, Vandenbossche F, Horovitz J, et al. First-trimester prenatal diagnosis performed on pregnant women with fetal ultrasound abnormalities: the reliability of interphase fluorescence in situ hybridization (FISH) on mesenchymal core for the main aneuploidies. Eur J Obstet Gynecol Reprod Biol. 2010;149(2):143-6. Epub 2010/01/05. doi: S0301-2115 (09) 00737-4 [pii]
28. Porreco RP, Garite TJ, Maurel K, Marusiak B, ObstetrixCollaborative Research N, Ehrich M, et al.. Noninvasive prenatal screening for fetal trisomies 21, 18, 13 and the common sex chromosome aneuploidies from maternal blood using massively parallel genomic sequencing of DNA. Am J Obstet Gynecol. 2014;211(4):365 e1-12. Epub 2014/03/25. doi: S0002-9378 (14) 00270-1 [pii]
29. Gil MM, Akolekar R, Quezada MS, Bregant B, Nicolaides KH. Analysis of cell-free DNA in maternal blood in screening for aneuploidies: meta-analysis. Fetal DiagnTher. 2014;35(3):156-73. Epub 2014/02/12. doi: 000358326 [pii]
30. Gerovassili A, Garner C, Nicolaides KH, Thein SL, Rees DC. Free fetal DNA in maternal circulation: a potential prognostic markerforchromosomal abnormalities? Prenat Diagn. 2007;27(2):104-10. Epub 2006/12/08.
31. Vora NL, Johnson KL, Basu S, Catalano PM, Hauguel-De Mouzon S, Bianchi DW. A multifactorial relationship exists between total circulating cell-free DNA levels and maternal BMI. Prenat Diagn. 2012;32(9):912-4. Epub 2012/06/22.
32. Rava RP, Srinivasan A, Sehnert AJ, Bianchi DW. Circulating fetal cell-free DNA fractions differ in autosomal aneuploidies and monosomy X. Clin Chem. 2014;60(1):243-50. Epub 2013/09/21. doi: clinchem.2013.207951 [pii]
33. Van Opstal D, de Vries F, Govaerts L, Boter M, Lont D, van Veen S, et al. Benefits and burdens of using a SNP array in pregnancies at increased risk for the common aneuploidies. Hum Mutat. 2015;36(3):319-26. Epub 2014/12/17.